Phlo, a Glasgow, UK-based provider of B2B digital pharmacy services, raised additional £9M in growth funding.
The round was led by Par Equity.
The company intends to use the funds to scale the digital healthcare business.
Led by CEO Nadeem Sarwar, Phlo is a provider of B2B digital pharmacy services and direct-to-door medication delivery. Their flagship product, Phlo Digital Pharmacy, is an NHS-approved pharmacy that allows patients to manage, order and track the delivery of their prescription medication via a secure app.
Their second product, Phlo Connect, is an API-driven digital infrastructure platform for healthcare providers. Their newest product, Phlo Clinic, provides patients with on-demand access to qualified clinicians who can issue and dispense regulated and approved treatments for direct-to-door delivery.
The Phlo ecosystem also includes the online women’s consumer health brand Hello Eve.
The company also acquired the assets of their former competitor TruePill UK. Phlo currently operates in Glasgow, London, Birmingham and Manchester. It currently has over 80,000 patients registered on its secure online prescribing platform and has delivered almost half a million medicines across the UK.
FinSMEs
18/04/2024